More than 100 volunteers from across Duke Health called more than 5,000 donors just to say "Thank you" for their support of Duke Health and all of its schools, institutes, and programs. Your gifts really do make a difference!

John Sampson, MD, PhD, MBA, MHSc, chair of the Department of Neurosurgery, discusses how the Duke Cancer Institute is studying DNA and genetics with the goal of creating each individual's unique cancer "fingerprint" to offer targeted therapies.

Audrey Odom John has established herself as a power player in the field of malaria research. She has shed light on new mechanisms of disease transmission and control.

Tolbert Wilkinson, MD’62, HS’64, a plastic surgeon, has thousands of people from all walks of life looking to erase their past and begin anew.

Priya Kishnani, MD, MBBS, discusses the power of innovation and discovery and how Duke researchers are leading the way to develop ground-breaking treatments for rare diseases like Pompe disease.

The Duke Eye Center dedicated the Frances and Stephen Foster Center for Ocular Immunology on October 9, 2018. This is a historic milestone for Duke Eye Center, as the Center is the first of its kind in the world.

Fumiko Chino, MD, a resident in radiation oncology, last summer co-authored research showing that the high cost of cancer care is a serious problem for many patients.

When K.V. Rajagopalan, PhD, arrived in the United States from India to begin his postdoctoral work in the Department of Biochemistry at Duke, he familiarized himself with the department’s members by reading their journal articles. Among them were a series of papers reporting startling research on oxygen radicals by a young biochemist named Irwin Fridovich, PhD’55.

When Brian Sullivan, MD was in college, his grandmother was diagnosed with colon cancer. Despite undergoing colonoscopy screenings every three years, her cancer was not identified early.

Why do perfectly good cancer treatments suddenly stop working? Researcher and lymphoma survivor Kris Wood is finding answers.